CNL Strategic Capital, LLC

$ Overview Financials Valuation SEC Filings Company Website

2024 Q2 Form 10-Q Financial Statement

#000168468224000020 Filed on August 08, 2024

Income Statement

Concept	2024 Q2

Balance Sheet

Concept	2024 Q2
SHORT-TERM ASSETS
Cash & Short-Term Investments
YoY Change
Cash & Equivalents	$124.2M
Short-Term Investments
Other Short-Term Assets
YoY Change
Inventory
Prepaid Expenses
Receivables
Other Receivables
Total Short-Term Assets
YoY Change
LONG-TERM ASSETS
Property, Plant & Equipment
YoY Change
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets
YoY Change
Total Long-Term Assets
YoY Change
TOTAL ASSETS
Total Short-Term Assets
Total Long-Term Assets
Total Assets	$1.131B
YoY Change	30.68%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable
YoY Change
Accrued Expenses
YoY Change
Deferred Revenue
YoY Change
Short-Term Debt
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities
YoY Change
LONG-TERM LIABILITIES
Long-Term Debt
YoY Change
Other Long-Term Liabilities
YoY Change
Total Long-Term Liabilities
YoY Change
TOTAL LIABILITIES
Total Short-Term Liabilities
Total Long-Term Liabilities
Total Liabilities	$34.54M
YoY Change	65.38%
SHAREHOLDERS EQUITY
Retained Earnings	$155.0M
YoY Change	48.97%
Common Stock
YoY Change
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity
YoY Change
Total Liabilities & Shareholders Equity
YoY Change

Cashflow Statement

Concept	2024 Q2

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value	Unit
	us-gaap	Noninterest Expense Transfer Agent And Custodian Fees NoninterestExpenseTransferAgentAndCustodianFees	278000	usd
	us-gaap	General Insurance Expense GeneralInsuranceExpense	106000	usd
CY2023Q2	us-gaap	Noninterest Expense Directors Fees NoninterestExpenseDirectorsFees	50000	usd
	us-gaap	Noninterest Expense Directors Fees NoninterestExpenseDirectorsFees	107000	usd
CY2024Q2	us-gaap	Stock Repurchased During Period Value StockRepurchasedDuringPeriodValue	12776000	usd
CY2024Q2	us-gaap	Assets Net AssetsNet	1096309000	usd
CY2023Q4	us-gaap	Assets Net AssetsNet	979349000	usd
	cnl	Net Change In Unrealized Appreciation Depreciation On Investments Net Of Taxes NetChangeInUnrealizedAppreciationDepreciationOnInvestmentsNetOfTaxes	35202000	usd
	us-gaap	Investment Company Dividend Distribution InvestmentCompanyDividendDistribution	18021000	usd
	us-gaap	Stock Issued During Period Value New Issues StockIssuedDuringPeriodValueNewIssues	107948000	usd
	us-gaap	Stock Issued During Period Value Dividend Reinvestment Plan StockIssuedDuringPeriodValueDividendReinvestmentPlan	8400000	usd
CY2023Q2	cnl	Investment Company Expense Support Subject To Reimbursement Accrued InvestmentCompanyExpenseSupportSubjectToReimbursementAccrued	402000	usd
	cnl	Investment Company Expense Support Subject To Reimbursement Accrued InvestmentCompanyExpenseSupportSubjectToReimbursementAccrued	0	usd
	cnl	Investment Company Expense Support Subject To Reimbursement Accrued InvestmentCompanyExpenseSupportSubjectToReimbursementAccrued	644000	usd
CY2023Q2	cnl	Operating Expenses Net OperatingExpensesNet	7878000	usd
	cnl	Operating Expenses Net OperatingExpensesNet	22093000	usd
	cnl	Operating Expenses Net OperatingExpensesNet	16312000	usd
CY2023Q2	cnl	Net Investment Income Loss Before Income Tax Expense Benefit NetInvestmentIncomeLossBeforeIncomeTaxExpenseBenefit	6628000	usd
	cnl	Net Investment Income Loss Before Income Tax Expense Benefit NetInvestmentIncomeLossBeforeIncomeTaxExpenseBenefit	9982000	usd
	cnl	Net Investment Income Loss Before Income Tax Expense Benefit NetInvestmentIncomeLossBeforeIncomeTaxExpenseBenefit	11512000	usd
	us-gaap	Current Income Tax Expense Benefit CurrentIncomeTaxExpenseBenefit	-5000	usd
	us-gaap	Current Income Tax Expense Benefit CurrentIncomeTaxExpenseBenefit	0	usd
	us-gaap	Net Investment Income NetInvestmentIncome	9987000	usd
	us-gaap	Net Investment Income NetInvestmentIncome	11512000	usd
CY2023Q2	us-gaap	Realized Investment Gains Losses RealizedInvestmentGainsLosses	0	usd
CY2023Q2	us-gaap	Unrealized Gain Loss On Investments UnrealizedGainLossOnInvestments	-482000	usd
	us-gaap	Unrealized Gain Loss On Investments UnrealizedGainLossOnInvestments	35202000	usd
	us-gaap	Unrealized Gain Loss On Investments UnrealizedGainLossOnInvestments	12606000	usd
CY2023Q2	us-gaap	Net Income Loss NetIncomeLoss	6119000	usd
	us-gaap	Net Income Loss NetIncomeLoss	45189000	usd
	us-gaap	Net Income Loss NetIncomeLoss	24122000	usd
	us-gaap	Net Investment Income NetInvestmentIncome	9987000	usd
	us-gaap	Net Income Loss NetIncomeLoss	45189000	usd
	cnl	Proceeds From Redemptions Sales Of Us Treasury Bills Operating Activities ProceedsFromRedemptionsSalesOfUSTreasuryBillsOperatingActivities	0	usd
	cnl	Net Change In Unrealized Appreciation On Investments NetChangeInUnrealizedAppreciationOnInvestments	36469000	usd
	us-gaap	Amortization Of Debt Discount Premium AmortizationOfDebtDiscountPremium	0	usd
	us-gaap	Increase Decrease In Accounts Payable Related Parties IncreaseDecreaseInAccountsPayableRelatedParties	-4662000	usd
	us-gaap	Increase Decrease In Accounts Payable And Other Operating Liabilities IncreaseDecreaseInAccountsPayableAndOtherOperatingLiabilities	-418000	usd
	cnl	Increase Decrease In Deferred Tax Liabilities IncreaseDecreaseInDeferredTaxLiabilities	1267000	usd
	us-gaap	Increase Decrease In Other Operating Assets IncreaseDecreaseInOtherOperatingAssets	143000	usd
	us-gaap	Other Operating Activities Cash Flow Statement OtherOperatingActivitiesCashFlowStatement	61000	usd
	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-87866000	usd
	cnl	Proceeds From Issuance Of Common Stock Gross ProceedsFromIssuanceOfCommonStockGross	109359000	usd
	us-gaap	Payments For Repurchase Of Common Stock PaymentsForRepurchaseOfCommonStock	22004000	usd
	us-gaap	Distribution Made To Limited Partner Cash Distributions Paid DistributionMadeToLimitedPartnerCashDistributionsPaid	9621000	usd
	us-gaap	Payments Of Financing Costs PaymentsOfFinancingCosts	163000	usd
	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	77571000	usd
	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	-10295000	usd
CY2023Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	134453000	usd
CY2022Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	36837000	usd
CY2024Q2	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	124158000	usd
	cnl	Proceeds From Distributions Reinvested ProceedsFromDistributionsReinvested	8400000	usd
	cnl	Accrued Offering Costs During Noncashor Partial Noncash Transaction AccruedOfferingCostsDuringNoncashorPartialNoncashTransaction	386000	usd
CY2023Q2	cnl	Payable For Shares Repurchased PayableForSharesRepurchased	6323000	usd
CY2023Q2	us-gaap	Noninterest Expense Transfer Agent And Custodian Fees NoninterestExpenseTransferAgentAndCustodianFees	140000	usd
	us-gaap	Noninterest Expense Transfer Agent And Custodian Fees NoninterestExpenseTransferAgentAndCustodianFees	267000	usd
CY2023Q2	us-gaap	General Insurance Expense GeneralInsuranceExpense	52000	usd
	us-gaap	General Insurance Expense GeneralInsuranceExpense	103000	usd
CY2024Q2	us-gaap	Noninterest Expense Directors Fees NoninterestExpenseDirectorsFees	54000	usd
CY2024Q2	us-gaap	Gross Investment Income Operating GrossInvestmentIncomeOperating	17155000	usd
CY2023Q2	us-gaap	Gross Investment Income Operating GrossInvestmentIncomeOperating	14506000	usd
	us-gaap	Gross Investment Income Operating GrossInvestmentIncomeOperating	32075000	usd
	us-gaap	Gross Investment Income Operating GrossInvestmentIncomeOperating	27824000	usd
CY2024Q2	us-gaap	Incentive Fee Expense IncentiveFeeExpense	5273000	usd
CY2023Q2	us-gaap	Incentive Fee Expense IncentiveFeeExpense	1332000	usd
	us-gaap	Incentive Fee Expense IncentiveFeeExpense	9758000	usd
	us-gaap	Incentive Fee Expense IncentiveFeeExpense	4967000	usd
CY2024Q2	us-gaap	Management Fee Expense ManagementFeeExpense	4208000	usd
CY2023Q2	us-gaap	Management Fee Expense ManagementFeeExpense	3174000	usd
	us-gaap	Management Fee Expense ManagementFeeExpense	8226000	usd
	us-gaap	Management Fee Expense ManagementFeeExpense	5837000	usd
CY2024Q2	cnl	Offering Costs Recognized As Organizational Cost Expense OfferingCostsRecognizedAsOrganizationalCostExpense	285000	usd
CY2023Q2	cnl	Offering Costs Recognized As Organizational Cost Expense OfferingCostsRecognizedAsOrganizationalCostExpense	1047000	usd
	cnl	Offering Costs Recognized As Organizational Cost Expense OfferingCostsRecognizedAsOrganizationalCostExpense	541000	usd
	cnl	Offering Costs Recognized As Organizational Cost Expense OfferingCostsRecognizedAsOrganizationalCostExpense	1951000	usd
CY2024Q2	us-gaap	Professional Fees ProfessionalFees	997000	usd
CY2023Q2	us-gaap	Professional Fees ProfessionalFees	511000	usd
	us-gaap	Professional Fees ProfessionalFees	1584000	usd
	us-gaap	Professional Fees ProfessionalFees	1011000	usd
CY2024Q2	cnl	Pursuit Costs PursuitCosts	497000	usd
CY2023Q2	cnl	Pursuit Costs PursuitCosts	361000	usd
	cnl	Pursuit Costs PursuitCosts	1002000	usd
	cnl	Pursuit Costs PursuitCosts	546000	usd
CY2024Q2	us-gaap	Expense Related To Distribution Or Servicing And Underwriting Fees ExpenseRelatedToDistributionOrServicingAndUnderwritingFees	319000	usd
CY2023Q2	us-gaap	Expense Related To Distribution Or Servicing And Underwriting Fees ExpenseRelatedToDistributionOrServicingAndUnderwritingFees	294000	usd
	us-gaap	Expense Related To Distribution Or Servicing And Underwriting Fees ExpenseRelatedToDistributionOrServicingAndUnderwritingFees	637000	usd
	us-gaap	Expense Related To Distribution Or Servicing And Underwriting Fees ExpenseRelatedToDistributionOrServicingAndUnderwritingFees	563000	usd
CY2024Q2	us-gaap	Noninterest Expense Transfer Agent And Custodian Fees NoninterestExpenseTransferAgentAndCustodianFees	134000	usd
CY2024Q2	us-gaap	General Insurance Expense GeneralInsuranceExpense	53000	usd
	us-gaap	Noninterest Expense Directors Fees NoninterestExpenseDirectorsFees	101000	usd
CY2024Q2	us-gaap	Administrative Fees Expense AdministrativeFeesExpense	132000	usd
CY2023Q2	us-gaap	Administrative Fees Expense AdministrativeFeesExpense	160000	usd
	us-gaap	Administrative Fees Expense AdministrativeFeesExpense	221000	usd
	us-gaap	Administrative Fees Expense AdministrativeFeesExpense	308000	usd
CY2024Q2	us-gaap	Operating Expenses OperatingExpenses	11952000	usd
CY2023Q2	us-gaap	Operating Expenses OperatingExpenses	7121000	usd
	us-gaap	Operating Expenses OperatingExpenses	22446000	usd
	us-gaap	Operating Expenses OperatingExpenses	15668000	usd
CY2024Q2	us-gaap	Investment Company Expense Offset Arrangement InvestmentCompanyExpenseOffsetArrangement	58000	usd
CY2023Q2	us-gaap	Investment Company Expense Offset Arrangement InvestmentCompanyExpenseOffsetArrangement	-355000	usd
	us-gaap	Investment Company Expense Offset Arrangement InvestmentCompanyExpenseOffsetArrangement	353000	usd
	us-gaap	Investment Company Expense Offset Arrangement InvestmentCompanyExpenseOffsetArrangement	0	usd
CY2024Q2	cnl	Investment Company Expense Support Subject To Reimbursement Accrued InvestmentCompanyExpenseSupportSubjectToReimbursementAccrued	0	usd
CY2024Q2	cnl	Operating Expenses Net OperatingExpensesNet	11894000	usd
CY2024Q2	cnl	Net Investment Income Loss Before Income Tax Expense Benefit NetInvestmentIncomeLossBeforeIncomeTaxExpenseBenefit	5261000	usd
CY2024Q2	us-gaap	Current Income Tax Expense Benefit CurrentIncomeTaxExpenseBenefit	-5000	usd
CY2023Q2	us-gaap	Current Income Tax Expense Benefit CurrentIncomeTaxExpenseBenefit	27000	usd
CY2024Q2	us-gaap	Net Investment Income NetInvestmentIncome	5266000	usd
CY2023Q2	us-gaap	Net Investment Income NetInvestmentIncome	6601000	usd
CY2024Q2	us-gaap	Realized Investment Gains Losses RealizedInvestmentGainsLosses	0	usd
	us-gaap	Realized Investment Gains Losses RealizedInvestmentGainsLosses	0	usd
	us-gaap	Realized Investment Gains Losses RealizedInvestmentGainsLosses	4000	usd
CY2024Q2	us-gaap	Investment Company Deferred Income Tax Unrealized Appreciation InvestmentCompanyDeferredIncomeTaxUnrealizedAppreciation	496000	usd
CY2023Q2	us-gaap	Investment Company Deferred Income Tax Unrealized Appreciation InvestmentCompanyDeferredIncomeTaxUnrealizedAppreciation	630000	usd
	us-gaap	Investment Company Deferred Income Tax Unrealized Appreciation InvestmentCompanyDeferredIncomeTaxUnrealizedAppreciation	1267000	usd
	us-gaap	Investment Company Deferred Income Tax Unrealized Appreciation InvestmentCompanyDeferredIncomeTaxUnrealizedAppreciation	2154000	usd
CY2024Q2	us-gaap	Unrealized Gain Loss On Investments UnrealizedGainLossOnInvestments	18972000	usd
CY2024Q2	us-gaap	Net Income Loss NetIncomeLoss	24238000	usd
CY2024Q1	us-gaap	Assets Net AssetsNet	1034233000	usd
CY2024Q2	us-gaap	Net Investment Income NetInvestmentIncome	5266000	usd
CY2024Q2	cnl	Net Change In Unrealized Appreciation Depreciation On Investments Net Of Taxes NetChangeInUnrealizedAppreciationDepreciationOnInvestmentsNetOfTaxes	18972000	usd
CY2024Q2	us-gaap	Investment Company Dividend Distribution InvestmentCompanyDividendDistribution	9214000	usd
CY2024Q2	us-gaap	Stock Issued During Period Value New Issues StockIssuedDuringPeriodValueNewIssues	55484000	usd
CY2024Q2	us-gaap	Stock Issued During Period Value Dividend Reinvestment Plan StockIssuedDuringPeriodValueDividendReinvestmentPlan	4344000	usd
	us-gaap	Stock Repurchased During Period Value StockRepurchasedDuringPeriodValue	26556000	usd
CY2024Q2	us-gaap	Assets Net AssetsNet	1096309000	usd
CY2023Q1	us-gaap	Assets Net AssetsNet	779960000	usd
CY2023Q2	us-gaap	Net Investment Income NetInvestmentIncome	6601000	usd
CY2023Q2	cnl	Net Change In Unrealized Appreciation Depreciation On Investments Net Of Taxes NetChangeInUnrealizedAppreciationDepreciationOnInvestmentsNetOfTaxes	-482000	usd
CY2023Q2	us-gaap	Investment Company Dividend Distribution InvestmentCompanyDividendDistribution	7195000	usd
CY2023Q2	us-gaap	Stock Issued During Period Value New Issues StockIssuedDuringPeriodValueNewIssues	68967000	usd
CY2023Q2	us-gaap	Stock Issued During Period Value Dividend Reinvestment Plan StockIssuedDuringPeriodValueDividendReinvestmentPlan	2976000	usd
CY2023Q2	us-gaap	Stock Repurchased During Period Value StockRepurchasedDuringPeriodValue	6323000	usd
CY2023Q2	us-gaap	Assets Net AssetsNet	844504000	usd
CY2022Q4	us-gaap	Assets Net AssetsNet	709099000	usd
	us-gaap	Net Investment Income NetInvestmentIncome	11512000	usd
	us-gaap	Realized Investment Gains Losses RealizedInvestmentGainsLosses	4000	usd
	cnl	Net Change In Unrealized Appreciation Depreciation On Investments Net Of Taxes NetChangeInUnrealizedAppreciationDepreciationOnInvestmentsNetOfTaxes	12606000	usd
	us-gaap	Investment Company Dividend Distribution InvestmentCompanyDividendDistribution	13796000	usd
	us-gaap	Stock Issued During Period Value New Issues StockIssuedDuringPeriodValueNewIssues	128327000	usd
	us-gaap	Stock Issued During Period Value Dividend Reinvestment Plan StockIssuedDuringPeriodValueDividendReinvestmentPlan	5566000	usd
	us-gaap	Stock Repurchased During Period Value StockRepurchasedDuringPeriodValue	8814000	usd
CY2023Q2	us-gaap	Assets Net AssetsNet	844504000	usd
	us-gaap	Net Income Loss NetIncomeLoss	24122000	usd
	cnl	Proceeds From Return Of Capital On Investment Operating Activity ProceedsFromReturnOfCapitalOnInvestmentOperatingActivity	592000	usd
	cnl	Proceeds From Return Of Capital On Investment Operating Activity ProceedsFromReturnOfCapitalOnInvestmentOperatingActivity	165000	usd
	cnl	Proceeds From Redemptions Sales Of Us Treasury Bills Operating Activities ProceedsFromRedemptionsSalesOfUSTreasuryBillsOperatingActivities	590824000	usd
	us-gaap	Realized Investment Gains Losses RealizedInvestmentGainsLosses	0	usd
	us-gaap	Realized Investment Gains Losses RealizedInvestmentGainsLosses	4000	usd
	cnl	Net Change In Unrealized Appreciation On Investments NetChangeInUnrealizedAppreciationOnInvestments	14760000	usd
	us-gaap	Amortization Of Debt Discount Premium AmortizationOfDebtDiscountPremium	-1787000	usd
	us-gaap	Increase Decrease In Accounts Payable Related Parties IncreaseDecreaseInAccountsPayableRelatedParties	-8421000	usd
	us-gaap	Increase Decrease In Accounts Payable And Other Operating Liabilities IncreaseDecreaseInAccountsPayableAndOtherOperatingLiabilities	-248000	usd
	cnl	Increase Decrease In Deferred Tax Liabilities IncreaseDecreaseInDeferredTaxLiabilities	2154000	usd
	us-gaap	Increase Decrease In Other Operating Assets IncreaseDecreaseInOtherOperatingAssets	62000	usd
	us-gaap	Other Operating Activities Cash Flow Statement OtherOperatingActivitiesCashFlowStatement	164000	usd
	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-101328000	usd
	cnl	Proceeds From Issuance Of Common Stock Gross ProceedsFromIssuanceOfCommonStockGross	102898000	usd
	us-gaap	Payments For Repurchase Of Common Stock PaymentsForRepurchaseOfCommonStock	4859000	usd
	us-gaap	Distribution Made To Limited Partner Cash Distributions Paid DistributionMadeToLimitedPartnerCashDistributionsPaid	8230000	usd
	us-gaap	Payments Of Financing Costs PaymentsOfFinancingCosts	125000	usd
	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	89684000	usd
	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	-11644000	usd
CY2023Q2	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	25193000	usd
	cnl	Proceeds From Distributions Reinvested ProceedsFromDistributionsReinvested	5566000	usd
	cnl	Accrued Offering Costs During Noncashor Partial Noncash Transaction AccruedOfferingCostsDuringNoncashorPartialNoncashTransaction	126000	usd
CY2024Q2	cnl	Payable For Shares Repurchased PayableForSharesRepurchased	12776000	usd
CY2024Q2	us-gaap	Investment Owned Percent Of Net Assets InvestmentOwnedPercentOfNetAssets	0.918
CY2024Q2	us-gaap	Investment Owned At Cost InvestmentOwnedAtCost	812667000	usd
CY2024Q2	us-gaap	Investment Owned At Fair Value InvestmentOwnedAtFairValue	1006003000	usd
CY2024Q2	cnl	Other Assets In Excess Of Liabilities Percent OtherAssetsInExcessOfLiabilitiesPercent	0.082
CY2024Q2	cnl	Other Assets In Excess Of Liabilities OtherAssetsInExcessOfLiabilities	90306000	usd
CY2024Q2	cnl	Net Assets Percent NetAssetsPercent	1.000
CY2024Q2	us-gaap	Assets Net AssetsNet	1096309000	usd
CY2023Q4	us-gaap	Investment Owned Percent Of Net Assets InvestmentOwnedPercentOfNetAssets	0.895
CY2023Q4	us-gaap	Investment Owned At Cost InvestmentOwnedAtCost	719976000	usd
CY2023Q4	us-gaap	Investment Owned At Fair Value InvestmentOwnedAtFairValue	876843000	usd
CY2023Q4	cnl	Other Assets In Excess Of Liabilities Percent OtherAssetsInExcessOfLiabilitiesPercent	0.105
CY2023Q4	cnl	Other Assets In Excess Of Liabilities OtherAssetsInExcessOfLiabilities	102506000	usd
CY2023Q4	cnl	Net Assets Percent NetAssetsPercent	1.000
CY2023Q4	us-gaap	Assets Net AssetsNet	979349000	usd
	cnl	Number Of Classes Of Stock NumberOfClassesOfStock	4	classofstock
CY2024Q2	cnl	Concentration Risk Cash And Cash Equivalents Percentage Of Total Net Assets ConcentrationRiskCashAndCashEquivalentsPercentageOfTotalNetAssets	0.072
	us-gaap	Use Of Estimates UseOfEstimates	<div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Use of Estimates</span></div>Management makes estimates and assumptions related to the reporting of assets and liabilities and the disclosure of contingent assets and liabilities to prepare the financial statements in conformity with GAAP. The uncertainty of future events may materially impact the accuracy of the estimates and assumptions used in the financial statements and related footnotes and actual results could differ from those estimates.
CY2024Q2	us-gaap	Investment Owned At Cost InvestmentOwnedAtCost	812667000	usd
CY2024Q2	us-gaap	Investment Owned At Fair Value InvestmentOwnedAtFairValue	1006003000	usd
CY2024Q2	cnl	Fair Value Percentage Of Investment Portfolio FairValuePercentageOfInvestmentPortfolio	1.000
CY2024Q2	us-gaap	Investment Owned Percent Of Net Assets InvestmentOwnedPercentOfNetAssets	0.918
CY2023Q4	us-gaap	Investment Owned At Cost InvestmentOwnedAtCost	719976000	usd
CY2023Q4	us-gaap	Investment Owned At Fair Value InvestmentOwnedAtFairValue	876843000	usd
CY2023Q4	cnl	Fair Value Percentage Of Investment Portfolio FairValuePercentageOfInvestmentPortfolio	1.000
CY2023Q4	us-gaap	Investment Owned Percent Of Net Assets InvestmentOwnedPercentOfNetAssets	0.895
CY2023Q4	cnl	Number Of Debt Investments On Non Accrual Status NumberOfDebtInvestmentsOnNonAccrualStatus	0	investment
CY2024Q2	cnl	Number Of Debt Investments On Non Accrual Status NumberOfDebtInvestmentsOnNonAccrualStatus	0	investment
CY2024Q2	cnl	Percentage Of Investment Portfolio Fair Value PercentageOfInvestmentPortfolioFairValue	1.000
CY2023Q4	cnl	Percentage Of Investment Portfolio Fair Value PercentageOfInvestmentPortfolioFairValue	1.000
	cnl	Number Of Significant Portfolio Companies Controlling Interest NumberOfSignificantPortfolioCompaniesControllingInterest	5	company
CY2024Q2	cnl	Number Of Significant Portfolio Companies Controlling Interest NumberOfSignificantPortfolioCompaniesControllingInterest	5	company
	cnl	Number Of Significant Portfolio Companies Controlling Interest NumberOfSignificantPortfolioCompaniesControllingInterest	5	company
CY2023Q2	cnl	Number Of Significant Portfolio Companies Controlling Interest NumberOfSignificantPortfolioCompaniesControllingInterest	5	company
CY2024Q2	us-gaap	Investment Owned At Fair Value InvestmentOwnedAtFairValue	1006003000	usd
CY2023Q4	us-gaap	Investment Owned At Fair Value InvestmentOwnedAtFairValue	876843000	usd
	cnl	Conditional Reimbursement Expiration Period ConditionalReimbursementExpirationPeriod	P3Y
	us-gaap	Investment Company Expense Offset Arrangement InvestmentCompanyExpenseOffsetArrangement	5100000	usd
CY2024Q2	cnl	Expense Support Not Reimbursed And Expired ExpenseSupportNotReimbursedAndExpired	200000	usd
	us-gaap	Investment Company Expense Offset Arrangement InvestmentCompanyExpenseOffsetArrangement	400000	usd
	us-gaap	Investment Company Expense Offset Arrangement InvestmentCompanyExpenseOffsetArrangement	0	usd
	us-gaap	Investment Company Expense Offset Arrangement InvestmentCompanyExpenseOffsetArrangement	353000	usd
CY2023	us-gaap	Investment Company Expense Offset Arrangement InvestmentCompanyExpenseOffsetArrangement	0	usd
CY2024Q1	us-gaap	Distribution Made To Limited Liability Company Llc Member Cash Distributions Declared DistributionMadeToLimitedLiabilityCompanyLLCMemberCashDistributionsDeclared	8807000	usd
CY2024Q1	cnl	Distributions Reinvested DistributionsReinvested	4056000	usd
CY2024Q1	us-gaap	Distribution Made To Limited Liability Company Llc Member Cash Distributions Paid DistributionMadeToLimitedLiabilityCompanyLLCMemberCashDistributionsPaid	4751000	usd
CY2023Q1	us-gaap	Distribution Made To Limited Liability Company Llc Member Cash Distributions Declared DistributionMadeToLimitedLiabilityCompanyLLCMemberCashDistributionsDeclared	6601000	usd
CY2023Q1	cnl	Distributions Reinvested DistributionsReinvested	2590000	usd
CY2023Q1	us-gaap	Distribution Made To Limited Liability Company Llc Member Cash Distributions Paid DistributionMadeToLimitedLiabilityCompanyLLCMemberCashDistributionsPaid	4011000	usd
CY2024Q2	us-gaap	Distribution Made To Limited Liability Company Llc Member Cash Distributions Declared DistributionMadeToLimitedLiabilityCompanyLLCMemberCashDistributionsDeclared	9214000	usd
CY2024Q2	cnl	Distributions Reinvested DistributionsReinvested	4344000	usd
CY2024Q2	us-gaap	Distribution Made To Limited Liability Company Llc Member Cash Distributions Paid DistributionMadeToLimitedLiabilityCompanyLLCMemberCashDistributionsPaid	4870000	usd
CY2023Q2	us-gaap	Distribution Made To Limited Liability Company Llc Member Cash Distributions Declared DistributionMadeToLimitedLiabilityCompanyLLCMemberCashDistributionsDeclared	7195000	usd
CY2023Q2	cnl	Distributions Reinvested DistributionsReinvested	2976000	usd
CY2023Q2	us-gaap	Distribution Made To Limited Liability Company Llc Member Cash Distributions Paid DistributionMadeToLimitedLiabilityCompanyLLCMemberCashDistributionsPaid	4219000	usd
	us-gaap	Distribution Made To Limited Liability Company Llc Member Cash Distributions Declared DistributionMadeToLimitedLiabilityCompanyLLCMemberCashDistributionsDeclared	18021000	usd
	cnl	Distributions Reinvested DistributionsReinvested	8400000	usd
	us-gaap	Distribution Made To Limited Liability Company Llc Member Cash Distributions Paid DistributionMadeToLimitedLiabilityCompanyLLCMemberCashDistributionsPaid	9621000	usd
	us-gaap	Distribution Made To Limited Liability Company Llc Member Cash Distributions Declared DistributionMadeToLimitedLiabilityCompanyLLCMemberCashDistributionsDeclared	13796000	usd
	cnl	Distributions Reinvested DistributionsReinvested	5566000	usd
	us-gaap	Distribution Made To Limited Liability Company Llc Member Cash Distributions Paid DistributionMadeToLimitedLiabilityCompanyLLCMemberCashDistributionsPaid	8230000	usd
	us-gaap	Investment Company Dividend Distribution InvestmentCompanyDividendDistribution	18021000	usd
	cnl	Distributions Declared Allocation Percentage DistributionsDeclaredAllocationPercentage	1.000
	us-gaap	Investment Company Dividend Distribution InvestmentCompanyDividendDistribution	13796000	usd
	cnl	Distributions Declared Allocation Percentage DistributionsDeclaredAllocationPercentage	1.000
	cnl	Shares Issued Including Reinvestments SharesIssuedIncludingReinvestments	3425000	shares
	cnl	Proceeds Including Distributions Reinvested ProceedsIncludingDistributionsReinvested	116348000	usd
CY2024Q2	us-gaap	Sale Of Stock Price Per Share SaleOfStockPricePerShare	33.98
	cnl	Shares Issued Including Reinvestments SharesIssuedIncludingReinvestments	4068000	shares
	cnl	Proceeds Including Distributions Reinvested ProceedsIncludingDistributionsReinvested	133893000	usd
CY2023Q2	us-gaap	Sale Of Stock Price Per Share SaleOfStockPricePerShare	32.93
CY2023Q2	us-gaap	Receivable From Shareholders Or Affiliates For Issuance Of Capital Stock ReceivableFromShareholdersOrAffiliatesForIssuanceOfCapitalStock	25400000	usd
	cnl	Stock Repurchase Program Authorized Amount Per Quarter Percent StockRepurchaseProgramAuthorizedAmountPerQuarterPercent	0.025
	cnl	Stock Repurchase Program Authorized Amount Per Year Percent StockRepurchaseProgramAuthorizedAmountPerYearPercent	0.10
	us-gaap	Stock Repurchased During Period Value StockRepurchasedDuringPeriodValue	26600000	usd
	us-gaap	Stock Repurchased During Period Value StockRepurchasedDuringPeriodValue	8800000	usd
	us-gaap	Stock Repurchased During Period Shares StockRepurchasedDuringPeriodShares	767000	shares
	us-gaap	Stock Repurchased During Period Value StockRepurchasedDuringPeriodValue	26556000	usd
CY2024Q2	cnl	Average Redemption Of Common Stock Price Per Share AverageRedemptionOfCommonStockPricePerShare	34.62
	us-gaap	Stock Repurchased During Period Shares StockRepurchasedDuringPeriodShares	265000	shares
	us-gaap	Stock Repurchased During Period Value StockRepurchasedDuringPeriodValue	8814000	usd
CY2023Q2	cnl	Average Redemption Of Common Stock Price Per Share AverageRedemptionOfCommonStockPricePerShare	33.25
CY2024Q2	cnl	Payable For Shares Repurchased PayableForSharesRepurchased	12800000	usd
CY2023Q4	cnl	Payable For Shares Repurchased PayableForSharesRepurchased	8200000	usd
CY2024Q2	us-gaap	Current Income Tax Expense Benefit CurrentIncomeTaxExpenseBenefit	-5000	usd
CY2023Q2	us-gaap	Current Income Tax Expense Benefit CurrentIncomeTaxExpenseBenefit	27000	usd
	us-gaap	Current Income Tax Expense Benefit CurrentIncomeTaxExpenseBenefit	-5000	usd
	us-gaap	Current Income Tax Expense Benefit CurrentIncomeTaxExpenseBenefit	0	usd
CY2024Q2	us-gaap	Deferred Income Tax Expense Benefit DeferredIncomeTaxExpenseBenefit	496000	usd
CY2023Q2	us-gaap	Deferred Income Tax Expense Benefit DeferredIncomeTaxExpenseBenefit	630000	usd
	us-gaap	Deferred Income Tax Expense Benefit DeferredIncomeTaxExpenseBenefit	1267000	usd
	us-gaap	Deferred Income Tax Expense Benefit DeferredIncomeTaxExpenseBenefit	2154000	usd
CY2024Q2	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	491000	usd
CY2023Q2	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	657000	usd
	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	1262000	usd
	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	2154000	usd
	us-gaap	Effective Income Tax Rate Continuing Operations EffectiveIncomeTaxRateContinuingOperations	0.027
	us-gaap	Effective Income Tax Rate Continuing Operations EffectiveIncomeTaxRateContinuingOperations	0.082
CY2024Q2	us-gaap	Deferred Tax Assets Operating Loss Carryforwards DeferredTaxAssetsOperatingLossCarryforwards	1203000	usd
CY2023Q4	us-gaap	Deferred Tax Assets Operating Loss Carryforwards DeferredTaxAssetsOperatingLossCarryforwards	1249000	usd
CY2024Q2	cnl	Deferred Tax Assets Unrealized Appreciation Depreciation On Investments DeferredTaxAssetsUnrealizedAppreciationDepreciationOnInvestments	537000	usd
CY2023Q4	cnl	Deferred Tax Assets Unrealized Appreciation Depreciation On Investments DeferredTaxAssetsUnrealizedAppreciationDepreciationOnInvestments	913000	usd
CY2024Q2	us-gaap	Deferred Tax Assets Other DeferredTaxAssetsOther	20000	usd
CY2023Q4	us-gaap	Deferred Tax Assets Other DeferredTaxAssetsOther	0	usd
CY2024Q2	us-gaap	Deferred Tax Assets Valuation Allowance DeferredTaxAssetsValuationAllowance	979000	usd
CY2023Q4	us-gaap	Deferred Tax Assets Valuation Allowance DeferredTaxAssetsValuationAllowance	1324000	usd
CY2024Q2	us-gaap	Deferred Tax Assets Net DeferredTaxAssetsNet	781000	usd
CY2023Q4	us-gaap	Deferred Tax Assets Net DeferredTaxAssetsNet	838000	usd
CY2024Q2	cnl	Deferred Tax Liabilities Unrealized Appreciation Depreciation On Investments DeferredTaxLiabilitiesUnrealizedAppreciationDepreciationOnInvestments	9510000	usd
CY2023Q4	cnl	Deferred Tax Liabilities Unrealized Appreciation Depreciation On Investments DeferredTaxLiabilitiesUnrealizedAppreciationDepreciationOnInvestments	8300000	usd
CY2024Q2	us-gaap	Deferred Income Tax Liabilities DeferredIncomeTaxLiabilities	9510000	usd
CY2023Q4	us-gaap	Deferred Income Tax Liabilities DeferredIncomeTaxLiabilities	8300000	usd
CY2024Q2	us-gaap	Deferred Tax Liabilities DeferredTaxLiabilities	8729000	usd
CY2023Q4	us-gaap	Deferred Tax Liabilities DeferredTaxLiabilities	7462000	usd
CY2024Q2	cnl	Number Of Portfolio Companies Which Met At Least One Of The Significant Tests Under Rule1001b Of Regulation Sx NumberOfPortfolioCompaniesWhichMetAtLeastOneOfTheSignificantTestsUnderRule1001bOfRegulationSX	5	portfoliocompany

Files In Submission

Name	View Source	Status
cnl-20240630_cal.xml	Edgar Link	unprocessable
cnl-20240630_def.xml	Edgar Link	unprocessable
0001684682-24-000020-index-headers.html	Edgar Link	pending
0001684682-24-000020-index.html	Edgar Link	pending
0001684682-24-000020.txt	Edgar Link	pending
0001684682-24-000020-xbrl.zip	Edgar Link	pending
cnl-20240630.htm	Edgar Link	pending
cnl-20240630.xsd	Edgar Link	pending
Financial_Report.xlsx	Edgar Link	pending
MetaLinks.json	Edgar Link	pending
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
R26.htm	Edgar Link	pending
R27.htm	Edgar Link	pending
R28.htm	Edgar Link	pending
R29.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R30.htm	Edgar Link	pending
R31.htm	Edgar Link	pending
R32.htm	Edgar Link	pending
R33.htm	Edgar Link	pending
R34.htm	Edgar Link	pending
R35.htm	Edgar Link	pending
R36.htm	Edgar Link	pending
R37.htm	Edgar Link	pending
R38.htm	Edgar Link	pending
R39.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R40.htm	Edgar Link	pending
R41.htm	Edgar Link	pending
R42.htm	Edgar Link	pending
R43.htm	Edgar Link	pending
R44.htm	Edgar Link	pending
cnl-20240630_lab.xml	Edgar Link	unprocessable
cnl-20240630_htm.xml	Edgar Link	completed
cnl-20240630_pre.xml	Edgar Link	unprocessable
FilingSummary.xml	Edgar Link	unprocessable
R45.htm	Edgar Link	pending
R46.htm	Edgar Link	pending
R47.htm	Edgar Link	pending
R48.htm	Edgar Link	pending
R49.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R50.htm	Edgar Link	pending
R51.htm	Edgar Link	pending
R52.htm	Edgar Link	pending
R53.htm	Edgar Link	pending
R54.htm	Edgar Link	pending
R55.htm	Edgar Link	pending
R56.htm	Edgar Link	pending
R57.htm	Edgar Link	pending
R58.htm	Edgar Link	pending
R59.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R60.htm	Edgar Link	pending
R61.htm	Edgar Link	pending
R62.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
report.css	Edgar Link	pending
scap63024ex311.htm	Edgar Link	pending
scap63024ex312.htm	Edgar Link	pending
scap63024ex321.htm	Edgar Link	pending
Show.js	Edgar Link	pending

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

CNL Strategic Capital, LLC

2024 Q2 Form 10-Q Financial Statement

#000168468224000020 Filed on August 08, 2024

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission